Clinical trials
Endocrine System Diseases trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 5 |
| Ascendis Pharma Endocrinology Division A/S | 4 |
| Ascendis Pharma A/S | 1 |
| AstraZeneca | 1 |
| Biohaven Therapeutics Ltd. | 1 |
| Celgene | 1 |
| Sumitomo Pharma America, Inc. | 1 |
| Turning Point Therapeutics, Inc. | 1 |
| University of Calgary | 1 |
| Victor Chang Cardiac Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endocrine System Diseases | 17 |
| Glucose Metabolism Disorders | 6 |
| Metabolic Diseases | 6 |
| Dwarfism, Pituitary | 5 |
| Endocrine Gland Neoplasms | 5 |
| Neoplasms | 5 |
| Neoplasms by Site | 5 |
| Diabetes Mellitus | 4 |
| Diabetes Mellitus, Type 2 | 4 |
| Failure to Thrive | 4 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.